tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

AbbVie expects strong company growth in 2026 despite Humira erosion

Expects product platform to drive “top tier performance” for remainder of decade. Says in good position to increase R&D spend.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1